Skip to content
The Piney Point

FDA scientists opposed the Trump administration's move to ease peptides access

FDA scientists opposed the Trump administration's move to ease peptides access
Photo: KPRC 2 / Click2Houston (NBC) · view original

A plan to give people in the United States easier access to unproven peptide drugs favored by Health Secretary Robert F. Kennedy Jr. was opposed by most Food and Drug Administration scientific staff members, who had limited input in drafting the policy, according to six people familiar with its d...

Sources and story details